Christine A Poon
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 650 | $652.68 | $424K | +11.3% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2,735 | $653.50 | $1.8M | +11.2% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,915 | $654.42 | $1.3M | +11.0% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 100 | $655.10 | $66K | +10.9% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 712 | $656.50 | $467K | +10.7% |
| Oct 31SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 388 | $657.29 | $255K | +10.5% |
- Sell
Director Christine A Poon sold $1.8M of REGN at $653.50 — cuts the stake by 33%.
- Sell
Director Christine A Poon sold $1.3M of REGN at $654.42 — cuts the stake by 35%.